|
|
Article: United States: CPEX Pharmaceuticals Inc partners with Serenity Pharmaceuticals on drug candidate for urology indication.
- Article from:
- TendersInfo
- Article date:
- August 7, 2008
CopyrightCOPYRIGHT 2008 Al Bawaba (Middle East) Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: pinto03
CPEX Pharmaceuticals Inc , a specialty pharmaceutical company, said on 4 August that it has entered into a collaboration with Serenity Pharmaceuticals, a privately held, New-York based start-up urology company, on an intranasal drug candidate for a urology indication. The partnership will use Serenity's drug candidate and CPEX's patented drug delivery technology. Serenity has filed an Investigational New Drug (IND) application with the FDA to initiate Phase I clinical testing. The company expects a potential worldwide market of ...
Related newspaper, magazine, and journal articles:
|
|
Article: CPEX Pharmaceuticals Reports Second-Quarter 2008 ...
Biotech Week;
August 27, 2008 ;
700+ words
...CPEX Pharmaceuticals, Inc. (NASDAQ ... year (see also CPEX Pharmaceuticals, Inc.). CPEX ... Agreement with Serenity Pharmaceuticals: On August 4 ... privately held Serenity Pharmaceuticals Corporation announced ...
|
|